FdaApplication
NDA 219070
Identifiers
- fda_app_no: NDA219070
Properties
| Property | Value |
|---|---|
| applicant_name | CRINETICS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2025-09-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PALSONIFY | PALTUSOTINE HYDROCHLORIDE | EQ 20MG BASE | TABLET;ORAL |
| PALSONIFY | PALTUSOTINE HYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL |
2 products